Cohere is a secure, enterprise-grade AI platform providing developers and businesses with access to advanced large language models. It specializes in text generation, summarization, semantic search, and retrieval-augmented generation (RAG), with a strong focus on data privacy, customizability through fine-tuning, and flexible deployment options including on-premises and private cloud.
InferKit was a web-based AI text generation tool and API, known for producing human-like text from user prompts. While it is now discontinued, it was a popular choice for writers, developers, and marketers for creative writing, content creation, and integrating natural language generation into applications.
Product overview
Cohere Product overview
Cohere is a secure, enterprise-grade AI platform providing developers and businesses with access to advanced large language models. It specializes in text generation, summarization, semantic search, and retrieval-augmented generation (RAG), with a strong focus on data privacy, customizability through fine-tuning, and flexible deployment options including on-premises and private cloud.
InferKit Product overview
InferKit was a web-based AI text generation tool and API, known for producing human-like text from user prompts. While it is now discontinued, it was a popular choice for writers, developers, and marketers for creative writing, content creation, and integrating natural language generation into applications.
Detailed feature comparison
| Feature | Cohere | InferKit |
|---|---|---|
| Primary category | Enterprise Solutions | Api |
| Added | 2025-08-16 | 2025-08-02 |
| Pricing | Freemium | Freemium |
| Official website | cohere.com | inferkit.com |
| Product type | Website | Website |
| Performance data | ||
| User rating | Not verified | Not verified |
| Comments | 0 | 0 |
| Monthly visits | 599.7K | 9.1K |
| Monthly growth | 11.7% | 6.6% |
| Favorites | 80 | 117 |
| Details | View details | View details |
Cohere vs InferKit monthly traffic
Compare Cohere and InferKit by monthly reach, traffic trend, visit depth, top regions, and acquisition sources.
How to interpret the traffic data
In the Cohere vs InferKit monthly traffic comparison, Cohere currently shows 599.7K visits and InferKit shows 9.1K; Cohere has about 66.1 times the visible traffic of InferKit, an absolute difference of about 590.6K visits. This reflects visible reach, not feature quality or paid users.
Both tools provide verified traffic details, so monthly trends, visit depth, regions, and acquisition sources can be compared on the same basis.
Cohere monthly traffic:
Latest traffic
Monthly traffic trend
- 2025/9: 776K Monthly visits
- 2026/1: 446K Monthly visits
- 2026/2: 459.3K Monthly visits
- 2026/3: 505.7K Monthly visits
- 2026/4: 536.7K Monthly visits
- 2026/5: 599.7K Monthly visits
Top regions
Top 5 countries/regions
| Country/region | Percentage | Traffic |
|---|---|---|
| 🇺🇸United States | 53.43% | 320.4K |
| 🇮🇳India | 19.68% | 118K |
| 🇨🇦Canada | 16.92% | 101.5K |
| 🇩🇪Germany | 4.99% | 29.9K |
| 🇬🇧United Kingdom | 4.98% | 29.9K |
Traffic sources
| Source type | Percentage | Traffic |
|---|---|---|
| Direct | 78.22% | 469.1K |
| Referral | 19.43% | 116.5K |
| 2.35% | 14.1K |
Search keywords
InferKit monthly traffic:
Latest traffic
Monthly traffic trend
- 2025/9: 4.6K Monthly visits
- 2026/1: 14.2K Monthly visits
- 2026/2: 10.3K Monthly visits
- 2026/3: 8.5K Monthly visits
- 2026/4: 8.5K Monthly visits
- 2026/5: 9.1K Monthly visits
Top regions
Top 5 countries/regions
| Country/region | Percentage | Traffic |
|---|---|---|
| 🇺🇸United States | 74.65% | 6.8K |
| 🇮🇳India | 9.67% | 877 |
| 🇵🇭Philippines | 7.67% | 696 |
| 🇮🇩Indonesia | 5.92% | 537 |
| 🇹🇷Turkey | 2.09% | 190 |
Traffic sources
| Source type | Percentage | Traffic |
|---|---|---|
| Direct | 92.14% | 8.4K |
| Referral | 7.86% | 713 |
Search keywords
Usage comparison
Compare the core capabilities of Cohere and InferKit
Cohere Core features
InferKit Core features
Use cases
Cohere Use cases
InferKit Use cases
Cohere vs InferKit:In-depth comparison and selection guidance
First decide whether the products solve the same kind of need
This in-depth Cohere vs InferKit comparison uses only the product records, taxonomy, audience, traffic, and community signals available on this page. Cohere is primarily listed under “Enterprise Solutions”, while InferKit is primarily listed under “Api”, so the first decision is whether your actual task matches their recorded scope.
The structured fields currently show these decision-relevant differences: Primary category (Cohere: Enterprise Solutions; InferKit: Api); Monthly visits (Cohere: 599.7K; InferKit: 9.1K); Monthly growth (Cohere: 11.7%; InferKit: 6.6%); Favorites (Cohere: 80; InferKit: 117); Website (Cohere: cohere.com; InferKit: inferkit.com). These facts are more useful for selection than brand visibility alone.
What market visibility and monthly traffic mean
In the Cohere vs InferKit monthly traffic comparison, Cohere currently shows 599.7K visits and InferKit shows 9.1K; Cohere has about 66.1 times the visible traffic of InferKit, an absolute difference of about 590.6K visits. This reflects visible reach, not feature quality or paid users.
Both tools provide verified traffic details, so monthly trends, visit depth, regions, and acquisition sources can be compared on the same basis.
If public market visibility is an important first-pass criterion, investigate Cohere first. The final choice should still follow taxonomy, use case, and a real trial because higher traffic does not prove broader capabilities or better workflow fit.
Product positioning, use cases, and roles
Cohere and InferKit currently overlap in shared categories: Api and Writing; shared tags: API, NLP, and text generation. This can place both on the same shortlist, but it does not prove equal implementation, depth, or cost.
Cohere's unique categories/tags are Enterprise Solutions, chatbot, data privacy, enterprise AI, fine-tuning, large language model, llm, and natural language processing; InferKit's are Content Creation, ai writer, content creation, creative writing, developer tool, and discontinued. These unique fields are the strongest differentiators: validate the product whose recorded scope matches the task instead of following traffic alone.
What ratings, comments, and favorites can tell you
Cohere has no verified rating, 0 comments, 80 favorites, and 79 likes;InferKit has no verified rating, 0 comments, 117 favorites, and 116 likes。
Neither product has enough rating or comment samples for a credible reputation ranking.
Selection guidance by actual need
When to evaluate Cohere first
Put Cohere on the priority trial list when the task aligns with “Enterprise Solutions” and especially Enterprise Solutions, chatbot, data privacy, enterprise AI, fine-tuning, and large language model. This follows recorded positioning and does not imply unlisted capabilities are absent.
Cohere also currently records: pricing is freemium, product type is website, 599.7K verified monthly visits, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
When to evaluate InferKit first
Put InferKit on the priority trial list when the task aligns with “Api” and especially Content Creation, ai writer, content creation, creative writing, developer tool, and discontinued. This follows recorded positioning and does not imply unlisted capabilities are absent.
InferKit also currently records: pricing is freemium, product type is website, 9.1K verified monthly visits, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
How to validate the recommendation before deciding
The available data describes positioning, public visibility, and community signals, but it cannot prove output quality, speed, integration effort, privacy, or long-term cost in your workflow. Before deciding, run the same representative tasks in Cohere and InferKit, then record completion time, accuracy, manual corrections, and the real paid threshold. A like-for-like trial turns this comparison into a defensible adoption decision.




